GPC3 and breast cancer: When considering cell type information, we found that GPC3-IGF1R interactions were most significant between cells expressing luminal androgen receptor (Luminal-AR) within DCIS and mesenchymal breast cancer cells surrounding the DCIS regions (Fig. 4i, j).